Cite
HARVARD Citation
Kang, M. et al. (2022). Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic. Journal of cerebral blood flow & metabolism. 42 (5), pp. 788-801. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kang, M. et al. (2022). Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic. Journal of cerebral blood flow & metabolism. 42 (5), pp. 788-801. [Online].